ANEB logo

Anebulo Pharmaceuticals (ANEB) Operating Profit

Annual Operating Profit

-$8.31 M
+$3.47 M+29.49%

30 June 2024

ANEB Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

-$2.17 M
-$826.40 K-61.65%

30 September 2024

ANEB Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$7.93 M
+$376.90 K+4.54%

30 September 2024

ANEB TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANEB Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.5%+21.5%+25.6%
3 y3 years-129.9%-102.3%-40.1%
5 y5 years---

ANEB Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-129.9%+29.5%-102.3%+43.2%-40.1%+32.7%
5 y5 years-129.9%+29.5%-758.8%+43.2%-3043.9%+32.7%
alltimeall time-129.9%+29.5%-758.8%+43.2%-3043.9%+32.7%

Anebulo Pharmaceuticals Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$2.17 M(+61.7%)
-$7.93 M(-4.5%)
June 2024
-$8.31 M(-29.5%)
-$1.34 M(-19.5%)
-$8.31 M(-12.2%)
Mar 2024
-
-$1.66 M(-39.7%)
-$9.46 M(-11.3%)
Dec 2023
-
-$2.76 M(+8.5%)
-$10.66 M(-9.0%)
Sept 2023
-
-$2.54 M(+2.0%)
-$11.72 M(-0.6%)
June 2023
-$11.78 M
-$2.49 M(-12.9%)
-$11.78 M(+1.5%)
Mar 2023
-
-$2.86 M(-24.9%)
-$11.61 M(+9.3%)
Dec 2022
-
-$3.81 M(+46.0%)
-$10.63 M(+34.8%)
DateAnnualQuarterlyTTM
Sept 2022
-
-$2.61 M(+12.3%)
-$7.89 M(+15.5%)
June 2022
-$6.83 M(+89.0%)
-$2.33 M(+23.7%)
-$6.83 M(-2.3%)
Mar 2022
-
-$1.88 M(+75.5%)
-$6.99 M(+23.4%)
Dec 2021
-
-$1.07 M(-31.1%)
-$5.66 M(+15.2%)
Sept 2021
-
-$1.55 M(-37.4%)
-$4.92 M(+36.0%)
June 2021
-$3.61 M
-$2.48 M(+350.0%)
-$3.61 M(+220.1%)
Mar 2021
-
-$552.10 K(+70.1%)
-$1.13 M(+95.7%)
Dec 2020
-
-$324.60 K(+28.7%)
-$576.90 K(+128.7%)
Sept 2020
-
-$252.30 K
-$252.30 K

FAQ

  • What is Anebulo Pharmaceuticals annual operaing income?
  • What is the all time high annual operating profit for Anebulo Pharmaceuticals?
  • What is Anebulo Pharmaceuticals annual operating profit year-on-year change?
  • What is Anebulo Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Anebulo Pharmaceuticals?
  • What is Anebulo Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Anebulo Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Anebulo Pharmaceuticals?
  • What is Anebulo Pharmaceuticals TTM operating profit year-on-year change?

What is Anebulo Pharmaceuticals annual operaing income?

The current annual operating profit of ANEB is -$8.31 M

What is the all time high annual operating profit for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals all-time high annual operaing income is -$3.61 M

What is Anebulo Pharmaceuticals annual operating profit year-on-year change?

Over the past year, ANEB annual operaing income has changed by +$3.47 M (+29.49%)

What is Anebulo Pharmaceuticals quarterly operating income?

The current quarterly operating profit of ANEB is -$2.17 M

What is the all time high quarterly operating profit for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals all-time high quarterly operating income is -$252.30 K

What is Anebulo Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, ANEB quarterly operating income has changed by +$593.70 K (+21.51%)

What is Anebulo Pharmaceuticals TTM operating income?

The current TTM operating profit of ANEB is -$7.93 M

What is the all time high TTM operating profit for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals all-time high TTM operating income is -$252.30 K

What is Anebulo Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, ANEB TTM operating income has changed by +$2.73 M (+25.61%)